391 related articles for article (PubMed ID: 15189916)
1. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study.
Wongsurakiat P; Maranetra KN; Wasi C; Kositanont U; Dejsomritrutai W; Charoenratanakul S
Chest; 2004 Jun; 125(6):2011-20. PubMed ID: 15189916
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.
Wongsurakiat P; Lertakyamanee J; Maranetra KN; Jongriratanakul S; Sangkaew S
J Med Assoc Thai; 2003 Jun; 86(6):497-508. PubMed ID: 12924797
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination.
Menon B; Gurnani M; Aggarwal B
Int J Clin Pract; 2008 Apr; 62(4):593-8. PubMed ID: 18284444
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study.
Wongsurakiat P; Maranetra KN; Gulprasutdilog P; Aksornint M; Srilum W; Ruengjam C; Sated W
Respirology; 2004 Nov; 9(4):550-6. PubMed ID: 15612969
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.
Mulpuru S; Li L; Ye L; Hatchette T; Andrew MK; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Powis J; Richardson D; Semret M; Shinde V; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA;
Chest; 2019 Jan; 155(1):69-78. PubMed ID: 30616737
[TBL] [Abstract][Full Text] [Related]
6. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination.
Gorse GJ; O'connor TZ; Young SL; Habib MP; Wittes J; Neuzil KM; Nichol KL
Chest; 2006 Oct; 130(4):1109-16. PubMed ID: 17035445
[TBL] [Abstract][Full Text] [Related]
7. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: A retrospective cohort study.
Regan AK; Klerk Nd; Moore HC; Omer SB; Shellam G; Effler PV
Vaccine; 2016 Jul; 34(32):3649-56. PubMed ID: 27216758
[TBL] [Abstract][Full Text] [Related]
9. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial].
Geppe NA; Kondiurina EG; Galustian AN; Pak TE; Bal'tserovich NB; Zhiglinskaia OV; Kamaev AV; Lazareva SG; Laléko SL; Mel'nikova IM; Perminova OA; Sabitov AU
Antibiot Khimioter; 2014; 59(5-6):6-14. PubMed ID: 25552038
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of an influenza vaccine in a working population in Colombia].
Mesa Duque SS; Pérez Moreno A; Hurtado G; Arbeláez Montoya MP
Rev Panam Salud Publica; 2001 Oct; 10(4):232-9. PubMed ID: 11715169
[TBL] [Abstract][Full Text] [Related]
11. Assessment of temporally-related acute respiratory illness following influenza vaccination.
Rikin S; Jia H; Vargas CY; Castellanos de Belliard Y; Reed C; LaRussa P; Larson EL; Saiman L; Stockwell MS
Vaccine; 2018 Apr; 36(15):1958-1964. PubMed ID: 29525279
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.
Shi M; An Q; Ainslie KEC; Haber M; Orenstein WA
BMC Infect Dis; 2017 Dec; 17(1):757. PubMed ID: 29216845
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial.
Gravenstein S; Davidson HE; Taljaard M; Ogarek J; Gozalo P; Han L; Mor V
Lancet Respir Med; 2017 Sep; 5(9):738-746. PubMed ID: 28736045
[TBL] [Abstract][Full Text] [Related]
14. Influenza virus vaccination of patients with chronic lung disease.
Gorse GJ; Otto EE; Daughaday CC; Newman FK; Eickhoff CS; Powers DC; Lusk RH
Chest; 1997 Nov; 112(5):1221-33. PubMed ID: 9367461
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.
Sanei F; Wilkinson T
Ther Adv Respir Dis; 2016 Aug; 10(4):349-67. PubMed ID: 27193567
[TBL] [Abstract][Full Text] [Related]
16. Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons.
De Serres G; Skowronski DM; Guay M; Rochette L; Jacobsen K; Fuller T; Duval B
Arch Intern Med; 2004 Nov; 164(20):2266-72. PubMed ID: 15534165
[TBL] [Abstract][Full Text] [Related]
17. Early estimates of seasonal influenza vaccine effectiveness--United States, January 2013.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jan; 62(2):32-5. PubMed ID: 23325354
[TBL] [Abstract][Full Text] [Related]
18. Seasonal influenza vaccination in patients with COPD: a systematic literature review.
Bekkat-Berkani R; Wilkinson T; Buchy P; Dos Santos G; Stefanidis D; Devaster JM; Meyer N
BMC Pulm Med; 2017 May; 17(1):79. PubMed ID: 28468650
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.
Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K
JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795
[TBL] [Abstract][Full Text] [Related]
20. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
